RNA biomarkers in colorectal cancer
Authors:
- Stephen A. BustinSBStephen A. Bustin
- Jamie MurphyJMJamie Murphy
Abstract
No abstract availableKeywords
This publication has 148 references indexed in Scilit:
- Down-regulation of KRAS-interacting miRNA-143 predicts poor prognosis but not response to EGFR-targeted agents in colorectal cancerBritish Journal of Cancer, 2012
- Potential responders to FOLFOX therapy for colorectal cancer by Random Forests analysisBritish Journal of Cancer, 2011
- Unique Ectopic Lymph Node-Like Structures Present in Human Primary Colorectal Carcinoma Are Identified by Immune Gene Array ProfilingThe American Journal of Pathology, 2011
- Fecal Tests: From Blood to Molecular MarkersCurrent Colorectal Cancer Reports, 2011
- Variations in stromal signatures in breast and colorectal cancer metastasesThe Journal of Pathology, 2010
- Why the need for qPCR publication guidelines?—The case for MIQEMethods, 2010
- Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trialThe Lancet, 2009
- Evolution and Functions of Long Noncoding RNAsCell, 2009
- Role of Cancer Microenvironment in Metastasis: Focus on Colon CancerCancer Microenvironment, 2008
- A molecular signature of metastasis in primary solid tumorsNature Genetics, 2002